LifeMD, Inc. (LFMD)
Last Price$5.7(1.1%)
Market Cap$231.9M
LFMD Rating
LFMD Quality rating performance
LFMD Intrinsic Value
Key Highlights:
As of Mar 18, 2025 LFMD Relative Value is $3.0, which is overvalued by 46.5%, compared to current share price of $5.7.
As of Mar 18, 2025 LFMD DCF Value is N/A, which is undervalued by N/A, compared to current share price of $5.7.
LFMD Share Price History
1W 1.3%
1M (31.8%)
6M 7.8%
YTD (33.0%)
1Y (47.9%)
3Y 56.5%
5Y 527.8%
10Y 841.7%
Share Price
Intrinsic Value
Drawdown
Total Return
vs SP500
vs NASDAQ
Crunching data... Almost there!
LFMD Stock Metrics
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Base
$231.9M
$212.1M
$185.0M
$8,697.6K
Shares Outstanding
41M
Employees
500
Growth (CAGR)
71.5%
24.4%
9.36%
103.1%
64.6%
(66.04%)
Profitability
99.4%
(4.7%)
(11.0%)
9.5%
4.7%
(46.4%)
Intrinsic Value
$3.1 (44.7% overvalued)
N/A
$3.1
(41.0%)
Valuation (LTM)
Return on Capital
Financial Health
($19.8M)
(2.3x)
(9.0x)
(376.2%)
Dividends
Earnings
May 06, 2025
MISS by (43.3%)
MISS by 28.6%
250.0%
4 Beat & 6 Miss
LFMD Stock Financials
LFMD Income Statement Metrics
Annual
Quarterly
LTM
LFMD Cash Flow Statement Metrics
Annual
Quarterly
LTM
Operating Cash Flow (OCF)
$17.5M +98.6% YoY
Capital Expenditure (CAPEX)
$0.0 +0.9% YoY
Free Cash Flow (FCF)
$17.5M +9,903.2% YoY
LFMD Income Statement Overview
Annual
Quarterly
LTM
Dec'15
Dec'16
Dec'17
Dec'18
Dec'19
Dec'20
Dec'21
Dec'22
Dec'23
Dec'24
LFMD Balance Sheet Overview
Annual
Quarterly
LTM
Dec'15
Dec'16
Dec'17
Dec'18
Dec'19
Dec'20
Dec'21
Dec'22
Dec'23
Dec'24
Assets
Liabilities
Total assets
$72.5T
Current assets ($48.7T, 67.3% of total)
$35.0T (48.3%)
$8,217.8B (11.3%)
Other current assets
$5,510.4B (7.6%)
Non-current assets ($23.7T, 32.7% of total)
$0.0 (0.0%)
$6,400.6B (8.8%)
$2,030.7B (2.8%)
Other non-current assets
$15.3T (21.1%)
Financial position
($19.8T)
Cash & Short-term
Investments
Total Debt
LFMD Stock Ratios
Annual
Quarterly
LTM
Industry Median
5Y Historical Average
Benchmark
LFMD Earnings Surprises
Crunching data... Almost there!
LFMD Dividends
LFMD Dividend Yield
Crunching data... Almost there!
LFMD Dividend Per Share
3Y
10Y
30Y
Annual
Quarterly
LTM
Competing with LFMD
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Quality rating | Intrinsic value | 1Y Return | Revenue | Free Cash Flow | Revenue growth | FCF margin | Gross margin | ROIC | Total Debt to Equity |
$231.9M | 5.9 | $3.1 44.7% overvalued | (47.9%) | $185.0M | $8,697.6K | 21.3% | 4.7% | 99.4% | (334.1%) | (376.2%) | |
$13.8B | 6.3 | $22.3 71.0% overvalued | 194.5% | $363.7M | ($705.8M) | 19.2% | (194.1%) | 75.7% | (208.7%) | 27.6% | |
$9,704.8M | 4.8 | $57.8 417.4% undervalued | (42.2%) | $150.4B | $0.0 | 5.6% | 0.0% | 17.6% | (26.9%) | 272.4% | |
$803.8M | 5.1 | $11.3 15.3% undervalued | (34.1%) | CN¥14.7B | CN¥104.7M | (2.2%) | 0.7% | 4.4% | (63.5%) | 75.6% | |
$169.9M | 6.5 | $3.9 85.3% undervalued | 20.9% | CA$522.3M | CA$25.8M | 7.1% | 4.9% | 18.3% | 4.4% | 51.3% | |
$84.1M | 5.4 | $10.6 161.2% undervalued | (15.1%) | $247.0M | $856.0K | (10.8%) | 0.3% | 26.2% | (1.5%) | 1.1% | |
$9,731.9K | 6.0 | $19.3 178.5% undervalued | 60.2% | $4,429.2K | ($7,299.5K) | (53.0%) | (164.8%) | (12.5%) | (323.3%) | 1.6% | |
$5,248.1K | 5.4 | $6.4 551.3% undervalued | (69.7%) | $147.1M | ($14.9M) | (4.9%) | (10.2%) | 20.2% | (20.8%) | 209.6% | |
$2,535.5K | 5.1 | $76.8 5,345.2% undervalued | (91.2%) | $23.8M | ($32.2M) | (28.6%) | (135.2%) | 6.7% | (344.1%) | 9.8% | |
$500.4K | 4.8 | $25.6 12,720.1% undervalued | (91.7%) | $35.9M | ($665.0K) | (19.6%) | (1.9%) | 89.1% | (12.6%) | (203.9%) | |
$1,286.0 | 5.1 | $16.1 8,042,553.1% undervalued | (99.9%) | $5,846.9K | ($2,765.4K) | (65.7%) | (47.3%) | (52.3%) | (85.0%) | 44.1% |
FAQ
What is LifeMD, Inc. (LFMD) stock rating?
As of today, LifeMD, Inc. has a stock rating of 6 (out of 10), which is considered Good.
is LifeMD, Inc. (LFMD) a good stock to buy?
As of today, LifeMD, Inc. has a Good stock rating, which is 44.7% overvalued. According to Value Sense backtesting, stocks with similar profile tend to underperform the market by 4.6%.